Will the Phase 2 trial "Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)" reach primary completion on or before Jul 2, 2027?

Resolves Yes if ClinicalTrials.gov record NCT07157787 (Alexion Pharmaceuticals, Inc.) shows an actual primary completion date on or before Jul 2, 2027. Registered date at generation: Jul 2, 2027.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Jul 2, 2027, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.